Laura von Soosten
1PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Jul 26, 2022
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.Romain Sigaud, Lisa Rösch, Charlotte Gatzweiler
Pageof 1
Frequent Collaborators
1 joint publications
Romain Sigaud
1 joint publications
Florian Selt
1 joint publications
Simay Ayhan
1 joint publications
Kathrin I Foerster
1 joint publications
Jürgen Burhenne
1 joint publications
Walter E Haefeli
1 joint publications
Felix Sahm
1 joint publications
Cornelis M van Tilburg
1 joint publications
Stefan M Pfister
1 joint publications
Brent L Kreider
